Home | Computer | Computer Science
5,6-Methylenedioxy-2-aminoindane (MDAI) is really a drug engineered in the 1990's by a squad led by David E. Nichols at Purdue University. It serves as some sort of non-neurotoxic and an extremely selective serotonin releasing compound (SSRA) in vitro and releases mild entactogen results in people. Chemistry The actual chemical structure of MDAI is undoubtedly indirectly extracted from that of the illicit drug MDA, but the alpha-methyl group of the alkylamino amphetamine side chain has been bound back to the benzene nucleus to create an indane ring system, which changes its pharmacological properties substantially. Results The family of drugs typified by MDMA produce their effects through multiple mechanisms of action inside body, and consequently develop three distinct cues which animals can be qualified to respond to: a stimulant cue typified by prescription drugs this kind of as methamphetamine, a hallucinogen cue typified by drugs this kind of as LSD and DOM, and an "entactogen-like" cue which is produced by drug treatments such as MDAI and MBDB. These drug treatments cause drug-appropriate responses in animals qualified to recognize the effects of MDMA, but do not generate responses in animals qualified selectively to respond to stimulants or hallucinogens. Due to the fact these compounds selectively release serotonin in the brain but have little effect on dopamine or noradrenaline levels, they can generate empathogenic results but with no any stimulant action, instead being somewhat Use in scientific investigation MDAI and other similar medicines have been widely employed in scientific research, as they are able to replicate numerous on the effects of MDMA, but without having causing the neurotoxicity which may perhaps be associated with MDMA and some related drugs
Article Source: http://www.gambling-articles.org
Mdai is being discussed more often in the news and online to find out more go to research chemicals store.
Please Rate this Article
5 out of 54 out of 53 out of 52 out of 51 out of 5
Not yet Rated